Table 11.12

Unadjusted Patient Survival, Heart Transplants

Survival at 3 Months, 1 Year, 3 Years, and 5 Years

  3 Months 1 Year 3 Years 5 Years
(Tx 2002 - 2003) (Tx 2002 - 2003) (Tx 2000 - 2003) (Tx 1998 - 2003)
N % Std. Err. N % Std. Err. N % Std. Err. N % Std. Err.
Total All 4,001 91.8% 0.4% 4,001 87.5% 0.5% 8,199 80.0% 0.5% 12,473 72.8% 0.5%
Primary Diagnosis Coronary Artery Disease 1,726 91.4% 0.7% 1,726 86.8% 0.8% 3,572 79.1% 0.7% 5,558 72.2% 0.7%
Cardiomyopathy 1,840 93.4% 0.6% 1,840 89.2% 0.7% 3,765 82.2% 0.7% 5,670 74.3% 0.7%
Congenital Heart Disease 329 86.3% 1.9% 329 82.7% 2.1% 641 74.0% 1.9% 920 68.5% 1.8%
Valvular Heart Disease 88 89.8% 3.2% 88 87.5% 3.5% 193 73.3% 3.5% 281 71.0% 3.4%
Other 18 83.3% 8.8% 18 72.2% 10.6% 28 70.7% 8.7% 43 66.1% 8.3%
Unknown 0 - - 0 - - 0 - - 1 100.0% 0.0%


Source: OPTN/SRTR Data as of May 2, 2005.

(+) = Values not determined due to insufficient follow-up.

(-) = Values not determined since there were no transplants in the category.

Cohorts are transplants performed during the years listed at the top of the table.

Patient survival follows patients from first transplant of this type until death.Counts for patient and graft survival are different because a patient may have more than one transplant for a type of organ.

Center volume = Center's yearly transplants performed during the base period, based on heart and heart-lung transplants.

Multi-organ transplants are excluded.

Medical urgency status codes have changed over time. See Technical Notes chapter for further information.